Nivolumab for adjuvant treatment of desmoplastic malignant melanoma: A case report
- 7 November 2019
- journal article
- letter
- Published by Wiley in The Journal of Dermatology
- Vol. 47 (1) , E6-E7
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- High response rate to PD-1 blockade in desmoplastic melanomasNature, 2018
- Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathwayNature Genetics, 2015
- Desmoplastic malignant melanoma: A clinicohistopathologic study of 25 casesCancer, 1988
- Desmoplastic malignant melanoma (A rare variant of spindle cell melanoma)Cancer, 1971